These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 19351550)

  • 41. Hematopoietic progenitor kinase 1 is a negative regulator of dendritic cell activation.
    Alzabin S; Bhardwaj N; Kiefer F; Sawasdikosol S; Burakoff S
    J Immunol; 2009 May; 182(10):6187-94. PubMed ID: 19414772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Dendritic cells and allergy].
    Ohshima Y
    Arerugi; 2008 Dec; 57(12):1265-9. PubMed ID: 19169080
    [No Abstract]   [Full Text] [Related]  

  • 43. Enhanced antigen presentation and CTL activity by transduction of mature rather than immature dendritic cells with octaarginine-modified liposomes.
    Homhuan A; Kogure K; Nakamura T; Shastri N; Harashima H
    J Control Release; 2009 May; 136(1):79-85. PubMed ID: 19344678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liposomes targeted to Fc receptors for antigen presentation by dendritic cells in vitro and in vivo.
    Serre K; Giraudo L; Leserman L; Machy P
    Methods Enzymol; 2003; 373():100-18. PubMed ID: 14714399
    [No Abstract]   [Full Text] [Related]  

  • 45. Liposomal Ag engrafted with peptides of sequence derived from HMGB1 induce potent Ag-specific and anti-tumour immunity.
    Faham A; Bennett D; Altin JG
    Vaccine; 2009 Sep; 27(42):5846-54. PubMed ID: 19660589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific cathepsin B inhibitor is cell-permeable and activates presentation of TTC in primary human dendritic cells.
    Reich M; Wieczerzak E; Jankowska E; Palesch D; Boehm BO; Burster T
    Immunol Lett; 2009 Apr; 123(2):155-9. PubMed ID: 19428564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease.
    Shale M; Ghosh S
    Gut; 2009 Sep; 58(9):1291-9. PubMed ID: 19671557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dendritic cell-based cancer immunotherapies.
    Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dendritic cell-based tumor immunotherapy.
    Kadowaki N; Kitawaki T
    Rinsho Ketsueki; 2009 May; 50(5):358-63. PubMed ID: 19483395
    [No Abstract]   [Full Text] [Related]  

  • 50. Octaarginine-liposomes as an effective vaccine carrier for mature dendritic cells.
    Park K
    J Control Release; 2009 May; 136(1):1. PubMed ID: 19351550
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.